United States
US 12,697,313 B2
Methods of treating anemia using formoterol or a pharmaceutically acceptable salt thereof
US 12,697,313 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Dana-Farber Cancer Institute, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Dana-Farber Cancer Institute, Inc.
- Inventors
- Laurie H. Glimcher; Shrestha Ghosh
- Publication date
- 2026-08-04
- Filing date
- 2025-05-02
- Document type
- B2 Granted patent
- Also written as
- US 12,697,313 B2 · US12697313 · 12697313
Abstract
The present invention provides methods of treating anemia in a patient in need thereof, comprising administering to the patient in need thereof an effective amount of formoterol or a pharmaceutically acceptable salt thereof (e.g., formoterol fumarate or arformoterol tartrate). The formoterol or a pharmaceutically acceptable salt thereof (e.g., formoterol fumarate or arformoterol tartrate) may be administered conjointly with an erythropoiesis-stimulating agent, optionally wherein the anemia is refractory to the erythropoiesis-stimulating agent.…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free